Your browser doesn't support javascript.
loading
Ectosomes from neutrophil-like cells down-regulate nickel-induced dendritic cell maturation and promote Th2 polarization.
Turbica, Isabelle; Gallais, Yann; Gueguen, Claire; Tharinger, Hugo; Al Sabbagh, Chantal; Gorges, Roseline; Gary-Gouy, Hélène; Kerdine-Römer, Saadia; Pallardy, Marc; Mascarell, Laurent; Gleizes, Aude; Chollet-Martin, Sylvie.
Afiliación
  • Turbica I; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Gallais Y; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Gueguen C; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Tharinger H; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Al Sabbagh C; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Gorges R; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Gary-Gouy H; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Kerdine-Römer S; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Pallardy M; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Mascarell L; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Gleizes A; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
  • Chollet-Martin S; *INSERM, UMR 996, Faculté de Pharmacie, Univ. Paris-Sud, Chatenay-Malabry, France; Institut Paris-Sud d'innovation thérapeutique (IPSIT), Univ. Paris-Sud, Châtenay-Malabry, France; UniverSud, Faculté de Pharmacie, Châtenay-Malabry, France; Stallergenes, Antony cedex, France; CNRS UMR, Institut Galie
J Leukoc Biol ; 97(4): 737-49, 2015 Apr.
Article en En | MEDLINE | ID: mdl-25673294
ABSTRACT
DCs are the first immune cells to be exposed to allergens, including chemical sensitizers, such as nickel, a human TLR4 agonist that induces DC maturation. In ACD, DCs can interact with PMNs that are recruited and activated, leading, in particular, to ectosome release. The objective of this work was to characterize the effects of PMN-Ect on DC functions in an ACD context. We first developed a standardized protocol to produce, characterize, and quantify ectosomes by use of human PLB-985 cells, differentiated into mature PMN (PLB-Ect). We then studied the in vitro effects of these purified ectosomes on human moDC functions in response to NiSO4 and to LPS, another TLR4 agonist. Confocal fluorescence microscopy showed that PLB-Ect was internalized by moDCs and localized in the lysosomal compartment. We then showed that PLB-Ect down-regulated NiSO4-induced moDC maturation, as witnessed by decreased expression of CD40, CD80, CD83, CD86, PDL-1, and HLA-DR and by decreased levels of IL-1ß, IL-6, TNF-α, and IL-12p40 mRNAs. These effects were related to p38MAPK and NF-κB down-regulation. However, no increase in pan-regulatory DC marker genes (GILZ, CATC, C1QA) was observed; rather, levels of effector DC markers (Mx1, NMES1) were increased. Finally, when these PLB-Ect + NiSO4-treated moDCs were cocultured with CD4(+) T cells, a Th2 cytokine profile seemed to be induced, as shown, in particular, by enhanced IL-13 production. Together, these results suggest that the PMN-Ect can modulate DC maturation in response to nickel, a common chemical sensitizer responsible for ADC.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Alérgenos / Antígenos CD / Regulación de la Expresión Génica / Linfocinas / Dermatitis Alérgica por Contacto / Células Th2 / Células Mieloides / Micropartículas Derivadas de Células / Neutrófilos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: J Leukoc Biol Año: 2015 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Dendríticas / Alérgenos / Antígenos CD / Regulación de la Expresión Génica / Linfocinas / Dermatitis Alérgica por Contacto / Células Th2 / Células Mieloides / Micropartículas Derivadas de Células / Neutrófilos Tipo de estudio: Etiology_studies Límite: Humans Idioma: En Revista: J Leukoc Biol Año: 2015 Tipo del documento: Article
...